Cancer survival in Africa, Asia, and Central America: a population-based study.

By R. Sankaranarayanan, R. Swaminathan, H. Brenner, Kexin Chen, K. Chia, J. Chen, S. Law, Y. Ahn, Y. Xiang, B. Yeole and 18 more. The Lancet Oncology, 2010

609 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/3cac5a65d47abb0ab6bd93aa0cae1bd7d6c2d69c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. J. Ferlay

In Oncology

1. J. Ferlay
2. F. Bray
3. A. Jemal
4. Isabelle Soerjomataram
5. R. Siegel
6. J. Llovet

Citations in the corpus

• Cervical cancer: A global health crisis (2017, background): “For all stages combined, the 3-year to 5-year survival rate from cervical cancer for many underdeveloped countries is <50%.(21) Death from cervical cancer often involves local disease progression, resulting in significant suffering, including ureteral obstruction, pain, and fistulas.”
• Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review (2021, background): “4% for localized and regional breast cancer respectively [10].”
• The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. (2012, positive): “Page 11 Much of the variation in breast cancer survival between countries is likely to be caused by disparities in early detection programs and access to appropriate treatment services [34, 68, 70, 78].”
• Global estimates of cancer prevalence for 27 sites in the adult population in 2008 (2013, methodology): “However, cervix cancer remains the most prevalent in a further 33 countries, predominantly in Sub-Saharan Africa and Southern Asia.”
• Cancer survival in China, 2003–2005: A population‐based study (2015, background): “We found regional differences in survival for all the common cancers between urban and rural areas, as in a previous study.(12) The excess hazard of death within 5 years of diagnosis in rural areas was almost 40%, even after correction for the higher background mortality in rural areas.”
• Urbanisation and health in China (2010, neutral): “BMC Cancer, 2011, 11: 364 [46] Sankaranarayanan R, Swaminathan R, Brenner H, et al.”